Research into palliative care top priority for cancer patients, says study

London, Mar 9 : In the first ever study of its kind, researchers from the University of Surrey with funding from the UK Oncology Nursing Society surveyed cancer patients and nurses to help identify priorities for future research into oncology nursing and how it should be delivered. During the study patients identified palliative and end-of-life care as top areas for future examination with particular focus on models of end-of-life care in the community and access to specialist palliative care within oncology services.

Dimension Therapeutics to Hold Full Year 2016 Financial Results and…

Dimension Therapeutics, Inc. , a biopharmaceutical company advancing novel, adeno-associated virus gene therapies targeting the liver, a key organ for human metabolism, today announced that it will report financial results for the full year ended December 31, 2016, on Thursday, March 9, 2017. Following distribution of the earnings release via wire services, Dimension Therapeutics will host a live conference call and webcast at 8:30 a.m. Eastern Time to review the Company’s financial results and provide a business update.

Reducing risk of suicide in cancer patients

… suicide also is higher among cancer patients: twice that of the general population. That higher rate is troubling for health professionals. In an effort to intervene earlier, researchers are developing a list of risk factors for depression among …

Colorectal cancer rates rise among young U.S. adults

A couple of years ago his doctor suggested a colonoscopy. But because Devries was far younger than the recommended age for a first colonoscopy – 50 for those with no family history, 45 for African-Americans – his insurer said it probably wouldn’t pay, and if it did, his high-deductible plan would leave him footing most of the bill.

Advaxis Announces FDA Acceptance of IND for Groundbreaking…

Advaxis, Inc. , a clinical-stage biotechnology company developing cancer immunotherapies, today announced that the U.S. Food and Drug Administration has indicated the Investigational New Drug application for ADXS-NEO, a personalized neoantigen-targeted approach to cancer immunotherapy that is being developed in collaboration with Amgen , can proceed. This ground-breaking IND paves the way for bringing a new precision immunotherapy for the treatment of cancers into the clinic this year.

Exercise more effective than meds at relieving fatigue for cancer patients

Exercise could be a more effective way of reducing cancer-related fatigue than medications suggests new research published this week in JAMA Oncology . Led by the Wilmot Cancer Institute at the University of Rochester in the state of New York, the study analyzed more than 11,000 patients across 113 unique studies that tested various treatments for cancer-related fatigue.

Children’s Hospital at St Francis receives check 28 mins ago

Dozens stood outside on the Children’s playground at St. Francis Hospital as Gold 4 Kids of Tulsa presented a check of $70,00 to the hospital’s staff. Gold 4 Kids, a cancer fundraising organization, focuses on raising money for research, clinical trails, and special projects in order to support the clinical pediatric oncology department at St. Francis hospital.

The new Ortenzio Cancer Center

PinnacleHealth and community leaders gather for the official Ribbon Cutting of the new Ortenzio Cancer Center at PinnacleHealth West Shore Campus, 2035 Technology Parkway on August 11, 2014. The center will provide comprehensive oncology services in multiple specialty areas, including cancer risk assessment, womenaEUs cancer treatment, radiation oncology, medical oncology, infusion services and cancer clinical trials.

Cleveland Clinic opening new cancer center

The new Cleveland Clinic Taussig Cancer Center will welcome patients March 6. The 377,000-square-foot facility, shown above, will house all outpatient cancer treatment services in one location, with the center’s medical and radiation oncologists, surgeons, nurses, genetic counselors, social workers and others working in one shared space to improve patient outcomes.

Advaxis to Host Research Reception at Society of Gynecologic Oncology …

Advaxis, Inc. , a clinical-stage biotechnology company developing cancer immunotherapies, will host a Research Reception during the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer. The reception will be held from 5:30-7:00 p.m. ET on Monday, March 13, in National Harbor Room 15 at the Gaylord Convention Center in National Harbor, MD.

Study highlights potential tolerability of single fraction of HDR…

Results from a new prospective clinical trial indicate that high-dose-rate brachytherapy administered in a single, 19 Gray treatment may be a safe and effective alternative to longer courses of HDR treatment for men with localized prostate cancer. The study is available online in the International Journal of Radiation Oncology Biology Physics , the flagship journal of the American Society for Radiation Oncology .

WellSpan Oncology Services, Cancer Care Associates of York first in…

WellSpan Health announced today that WellSpan Oncology Services and Cancer Care Associates of York are the first in the United States selected to participate in an international research study to test the effectiveness of a specific drug combination to treat breast cancer. ” said Douglas Arbittier, M.D., vice president of WellSpan’s Oncology Service Line.

Rihanna glamorous in a grey dress during Harvard visit

‘So I made it to Harvard!’: High school dropout Rihanna is overwhelmed as Ivy League school honors her with Humanitarian of the Year Award On Monday, the pop star made an appearance at the Ivy League school to accept a plaque given to her by Allen Counter, the director of the Harvard Foundation. The 29-year-old, who never graduated high school, earned the prestigious award thanks to her various charitable efforts, including her role in creating an oncology center in her birthplace of Barbados.

Gene Therapy Shows Promise for Aggressive Lymphoma

An experimental gene therapy for aggressive non-Hodgkin lymphoma beat back more than a third of cancers that seemed untreatable, the therapy’s developers report. Thirty-six percent of over 100 very ill lymphoma patients appeared disease-free six months after a single treatment, according to results released by the treatment’s maker, Kite Pharma of Santa Monica, Calif.

Sheldon M. Feldman M.D. Named Chief, Division of Breast Surgery &…

Sheldon M. Feldman, M.D., has been named chief of the division of breast surgery and surgical oncology, and director of Breast Cancer Services at Montefiore Einstein Center for Cancer Care , the clinical arm of the NCI-designated Albert Einstein Cancer Center. He will also join the faculty of Albert Einstein College of Medicine as a professor of clinical surgery.

Turn awareness into action, Malaysians urged

… it but many people who are well generally do not care until they see the urgency, she says. “We need to improve health literacy and encourage people to take preventive steps and ensure early detection to increase chances of survival,” she says in a …

A cool head in a crisis – all thanks to MoonWalkers

Thousands of women with breast cancer could be spared the devastation of hair loss thanks to a cooling cap worn during chemotherapy that could halve the chance of patients losing their hair. Scalp cooling systems, which use either a cold gel or a refrigerated pump system to lower the temperature of the head, have been available for years for use during chemotherapy but have never been widely taken up.

When cancer treatments do more harm than good

When my 80-year-old father was diagnosed with Hodgkin’s disease, he was so weak that he could no longer walk, and his oncologist worried that chemotherapy might do more harm than good. But there was a new drug available, a “targeted therapy” that uses antibodies to destroy cancer cells while apparently leaving the rest of the patient’s cells alone.

Working to beat the odds on a killer cancer

… Ovarian Cancer Australia board member Tracey Curro and CEO Jane Hill with Opposition Leader Bill Shorten and Shadow Health Minister Catherine King at morning tea during a visit to the Queen Victoria Women’s Centre in Melbourne last year. Picture: …